Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Menotropin (drug) — also listed as: highly purified menotropins, Menopur®, hMG
• Progestrone vaginal insert (drug) — also listed as: progesterone, Endometrin®
• follitropin beta (drug) — also listed as: Follistim Pen®, Follistim®
• Progesterone in oil (drug)
• Ganirelix (drug) — also listed as: ganirelix acetate, GnRH antagonist

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Huntington Reproductive Center
  Pasadena, California, United States
  Site recruitment: Not reported
• San Diego Fertility Center
  San Diego, California, United States
  Site recruitment: Not reported
• Conceptions Reproductive Associates of Colorado
  Littleton, Colorado, United States
  Site recruitment: Not reported
• Women's Medical Research Group, LLC
  Clearwater, Florida, United States
  Site recruitment: Not reported
• The Advanced IVF Institute; Charles E. Miller, MD & Associates
  Naperville, Illinois, United States
  Site recruitment: Not reported
• A Woman's Center for Reproductive Medicine
  Baton Rouge, Louisiana, United States
  Site recruitment: Not reported
• Center for Assisted Reproduction
  Bedford, Texas, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• NTx™-265: rhCG, then rEPO (drug) — also listed as: Ovidrel, Epogen
• Saline Placebo (drug) — also listed as: Sodium Chloride 0.9%

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Hoag Memorial Hospital Presbyterian
  Newport Beach, California, United States
  Site recruitment: Not reported
• University of California, Irvine Medical Center
  Orange, California, United States
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• HCG (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Uzbrussel
  Brussels, Laarbeeklaan 101, Belgium
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• 16mm triggering (other)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The registry does not list facilities in this record. This does not mean the study has no sites.

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• low dose human chorionic gonadotropin (drug) — also listed as: human chorionic gonadotropin
• Clomiphen citrate plus HMG (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Royan institute, Reproductive Medicine Research Centre, ACECR
  Tehran, Tehran Province, Iran
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Extended letrozole regimen (drug) — also listed as: letrozole 2.5mg/day from cycle day 1 to 9
• Clomiphene citrate regimen (drug) — also listed as: Clomiphene citrate 100mg/day from cycle day 3 to 7

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Ahmed Elgazzar hospital
  Cairo, Egypt
  Site recruitment: Not reported
• Cairo university hospital
  Cairo, Egypt
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• s.c. human chorionic gonadotropin (Pregnyl) (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Hadassah Medical center
  Jerusalem, Israel
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• hCG-IBSA (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Department of Gynecology and Obstetrics Universitätfrauenklinik
  Basel, Switzerland
  Site recruitment: Not reported
• 4. Department of Gynecology and Obstetrics Frauenklinik, InselspitalEffingerstrasse 102
  Bern, Switzerland
  Site recruitment: Not reported
• Department of Gynecology and ObstetricsUniversity Hospital
  Geneva, Switzerland
  Site recruitment: Not reported
• 3. Maternity CHUV - Centre Hospitalier Universitaire Vaudois
  Lausanne, Switzerland
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Ovitrelle (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Hadassah Medical Center
  Jerusalem, Israel, Israel
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Male Infertility Protocol (procedure)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

The registry does not list facilities in this record. This does not mean the study has no sites.

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• NTx 265 (drug) — also listed as: Eprex, Ortho Biotech, Ovidrel, Serono

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Foothills Medical Center
  Calgary, Alberta, Canada
  Site recruitment: Recruiting

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• human chorionic gonadotropin (drug) — also listed as: Pregnyl, NV Organon, Oss, The Netherlands
• recombinant gonadotropins (drug) — also listed as: Puregon, NV Organon, Oss, The Netherlands

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• UZ Brussel
  Laarbeeklaan 101, Brussels Capital, Belgium
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• rFSH (drug)
• human chorionic gonadotropin (drug)
• human chorionic gonadotropin (drug)
• human chorionic gonadotropin (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• The Fertility Clinic, Rigshospitalet
  Copenhagen, Denmark
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Gonal F (drug)
• Luveris (drug)
• Cetrotide (drug)
• hCG (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Genesis Fertility Centre
  Vancouver, British Columbia, Canada
  Site recruitment: Not reported
• Department of Obstetrics, Gynecology and Reproductive Sciences, University of Saskatchewan
  Saskatoon, Saskatchewan, Canada
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• human menopausal gonadotropin (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• UZ Brussel
  Laarbeeklaan 101, Brussels Capital, Belgium
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• freezing embryos by vitrification (procedure) — also listed as: cryopreservation of embryos
• fresh embryo transfers (procedure) — also listed as: embryo transfer using fresh embryos
• buserelin (drug) — also listed as: suprefact
• recombinant FSH (drug) — also listed as: Gonal F
• human chorionic gonadotropin (pregnyl) (drug) — also listed as: pregnyl

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• : Research and clinical center for infertility
  Yazd, Yazd Province, Iran
  Site recruitment: Recruiting

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• 10000 IU urinary HCG (drug)
• 250 mcg recombinant HCG (drug)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Centre for Reproductive Medicine, UZ Brussel
  Brussels, Jette, Belgium
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Luveris (drug) — also listed as: Gonal-f, ovidrel

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Peking University third Hospital
  Beijing, Beijing Municipality, China
  Site recruitment: Not reported

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

• Mild Ovarian Stimulation Treatment (procedure)
• Conventional Ovarian Stimulation Treatment (procedure)

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

• Erasmus Medical Center
  Rotterdam, South Holland, Netherlands
  Site recruitment: Not reported